FDA Investigator Susan P Bruederle

Susan P Bruederle has conducted inspections on 97 sites in 9 countries as of 07 Aug 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
97
Last Inspection Date:
07 Aug 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, France, United Kingdom of Great Britain and Northern Ireland, Switzerland, Ireland, Germany, Canada, Italy, Portugal
FDA Investigators that have inspected at least one site in common with Susan P Bruederle:
Ademola O Daramola, Aditi S Thakur, Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda L Baskin, Amanda S Zorn, Amina Bashir, Amy Devlin, PhD, Anastasia G Lolas, Anastasia M Shields, Anders W Evenson, Andrace L Deyampert, Andrea D Swingle, Andrew A Leboeuf, Andrew F Shrake, Andrew J Barrowcliff, Angel S Johnson, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Ariel Cruz Figueroa, Arsen Karapetyan, Ashley L Reiber, Ashutosh Rao, PhD, Azza Talaat, Barry Cherney, PhD, Bei Y He, Benjamin J Smith, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brentley S Collins, Brian D Garthwaite, Brian D Nicholson, Brian D Rogers, Brittani N Franklin, Brittany D Terhar, Brooke K Higgins, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Byungja E Marciante, Carl A Anderson, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, Caryn M Mcnab, Catherine V Quinlan, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chad E Schmear, Chad W Rice, Charisse K Green, Charles I Ann, Charles L Zhou, Cheryl A Kmiec, Christian D Lynch (CDL), Christina A Miller, Christina V Santos, Christine W Twohy, Christopher D Leach, Chryste D Best, Claire M Minden, Constantin Y Philopoulos, Corrine M Carter, Cynthia J Lee, MS, Cynthia Jim, CSO, Danial S Hutchison, Daniel B Arrecis, Daniel J Brown, Dariusz Galezowski, Darrell E Luedtke, Darren S Morgan, David A Paterson, David D Anderson, PhD, David J Gasparovich, David L Duncan, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Deborah M Trout, Debra I Love, Denarvis C Mendenhall, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Devaughn Edwards, Dina A Tallman, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna A Katz, Donna Mwilliams Hill, PhD, Dr. Abhijit Raha, PhD, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Eboni S Funderburk, Edwin Melendez, Eliezar Ramos, Elizabeth L Philpy, Emest F Bizjak, Emily J Orban, Enrico Joset Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Erika V Butler, Etty Feller, Felix Maldonado, Frances Namuswe, PhD, Frank Wackes, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Gerald B Seaborn, Jr, Gerard Pde Leon, Goran Periz, PhD, Greg Brinsley, Gregory Price, Gregory R Brinsley, Gregory R Dill, Guerlain Ulysse, Gwyn G Dickinson, Heika R Tait, Helen B Ricalde, Herbert M Corbello, Howard Sklamberg, Hugh M Mcclure, II, Humera T Khan, Iram R Hassan, PhD, Ivis L Negron, Jacob G Lutz, Jacqueline Mdiaz Albertini, James I Giefer, James K Ireland, James L Dunnie, Jr, James W Plucinski, Janae D Price, Janet L Bowen, Janis R Armedoriz, Jason F Chancey, Jean Blackston Hill, Jeanne J Chiu, Jeanne M Morris, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer A Kemp, Jennifer C Adams, Jennifer C Johnson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer L Schmidt, Jennifer M Gogley, Jeremy W Rotton, Jesse A Vazquez, Joanne E King, Joanne Heim, Joey V Quitania, John Godshalk, John M Seale, John Misock, Jonathan G Swoboda, Jorge F Christian, Jorge L Guadalupe, Joris Vanloco, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose R Lopez, Joseph A Morkunas, Joseph A Piechocki, Joseph R Strelnik, Joshua M Adams, Juhong Liu, PhD, Junho Pak, Justin A Boyd, Karen Emasley Joseph, Karen M Montgomery (KMM), Katherine Szestypalow, Kathryn E Ogger, Kathy E Craven, Kathy E Noe, Kellia N Hicks, Kevin A Gonzalez, Kevin D Kallander, Kevin P Regan, Khoa Nathanv Tran, Kim Lthomas Cruse, Kshitij A Patkar, Kyran R Gibson, L'oreal F Walker, Lance Mde Souza, MBA, Larry K Austin, Latoya A Griffith, Laura Fontan, MS, Laurel A Beer, Lauren Iacono Connors, PhD, Laurie A Haxel, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, LCDR Randall L Morris, Leigh Anne Myers, Lequita M Mayhew, Leslie A Paul, Lewis K Antwi, Libia M Lugo, Linda F Murphy, Lindsey M Schwierjohann, Lindsey S Fleischman, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Lorie S Hannappel, Luella J Rossi, Lynda L Lanning, M A Abel I, Madushini Dharmasena, PhD, Maksim A Levenchuk, Margaret M Annes, Margaret Torres Vazquez, Maria Joselopez Barragan, PhD, Marianela Aponte Cruz, Marion Michaelis, Marisa E Stock, Mark E Frank, Mark G Peterson, Martha Sullivan Myrick, Martin R Vowell, Mary E Storch, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melanie M Walker, Melina Lrodriguez Upton, Melissa J Garcia, Mercy Oyugi, Meredith P Soehl, Investigator, Michael A Charles, Michael D Robinson, Michael E Maselli, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Milva E Melendez Perales, Mindy M Chou, Minh D Phan, Mizanne E Lewis, Montgomery Montgomery, Karen M, Mra Davism, Mra Mcculloughj, Mra Narulaa, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nayan J Patel, Neali H Lucas, Nebil A Oumer, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Noreen Muñiz, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Parul M Patel, Patricia A Cochran, Patricia A Mcilroy, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Peng Zhou, Pete Amin (Pankaj), Philip A Klimkewicz, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Rachel T Evans, Rafael Nevarez Nieves, Rafael Padilla, Rafeeq A Habeeb, Ralph A Erickson, Ralph H Vocque, Ramon E Martinez, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Renee S Blosser, Reyes Candau Chacon, PhD, Richard H Penta, Richard Heath Coats, Richard L Friedman, Richard T Riggie, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert M Barbosa, Robert M Tillman, Robert R Barbosa, Robert Rodriguez, Roberta W Cunningham, Roger F Zabinski, Rona Leblanc, PhD, Ronald G Crawford, Rose Ashley, Rose Xu, Roshni J Patel, Ross J Grigsby, Russ R Rivy, Russell K Riley, Ruth Moore, PhD, S Lori Brown, PhD MPH, Samina S Khan, Samuel W Labinjo, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Santos E Camara, Sarah E Rhoades, Sarah M Napier, Sarah Nwandiuko, Sarah Rhoades, Satheesh Thomas, Scott A Golladay, Scott T Ballard, Shafiq S Ahadi, Shana L Williams, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Steven C Madzo, Steven M Weinman, Steven P Donald, Sudha Shukla, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan W Ciani, Susanna E Ford, Suyang Qin, Tamara Brey, Tamil Arasu, PhD, Tara R Gooen, That Q Dang, Thomas A Peter, Thomas E Friel, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Schell, Tina M Pawlowski, Todd M Stankewicz, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Tyler M Peterson, Unnee Ranjan, Vaishali J Patel, Vioela J Caze, Walden H Lee, Wayne E Seifert, Wendy G Tan, PhD, William D Sherman, William D Tingley, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoping Guan, Xiomara Copeland, Yangmin Ning, Yasamin Ameri, Ying Xin Fan, PhD, Yonggang Wang, PhD, Yumi J Hiramine, Yvonne E Lozano, Zhong Li, PhD, Zonglin Hu

Susan P Bruederle's Documents

Publish Date Document Type Title
March, 2002 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2002-03-08
November, 2006 FDA 483 Response FIRST PRIORITY INCORPORATED - Form 483R, 2007-02-16
June, 2002 FDA 483 Response Labcorp Drug Development Inc. - Form 483R, 2002-06-14
May, 2005 EIR Eli Lilly and Company - EIR, 2005-05-19
May, 2003 EIR Eli Lilly and Company - EIR, 2003-05-29
November, 2006 FDA 483 FIRST PRIORITY INCORPORATED - Form 483, 2006-11-09
June, 2007 FDA 483 HIKMA FARMACEUTICA (PORTUGAL), S.A - Form 483, 2007-06-08
September, 2003 FDA 483 Response Bespak HC Limited - Form 483R, 2003-09-23
November, 2000 FDA 483 Aventis Pharma, Ltd. - Form 483, 2000-11-17
March, 2005 FDA 483 Response ACS DOBFAR SPA - Form 483R, 2005-04-04
January, 2000 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2000-01-11
August, 2003 EIR Fresenius Kabi USA, LLC - EIR, 2003-08-14
November, 2001 FDA 483 Response Sanofi Winthrop Industrie - Form 483R, 2001-12-17
November, 2006 EIR FIRST PRIORITY INCORPORATED - EIR, 2006-11-09
August, 2003 EIR Degussa Limited - EIR, 2003-11-12
May, 2003 FDA 483 Eli Lilly and Company - Form 483, 2003-05-29
June, 2002 EIR Labcorp Drug Development Inc. - EIR, 2002-03-22
April, 2001 FDA 483 AbbVie Inc. - Form 483, 2001-04-30
May, 2002 EIR Eli Lilly and Company - EIR, 2002-05-30
August, 2003 FDA 483 Response Degussa Limited - Form 483R, 2003-12-01
March, 2002 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2002-03-08
September, 2003 EIR SF-Chem - EIR, 2003-09-09
August, 2003 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2003-08-14
May, 2002 FDA 483 Eli Lilly and Company - Form 483, 2002-05-30
April, 2001 EIR AbbVie Inc. - EIR, 2001-04-30
September, 2000 EIR Rising Pharma Holdings, Inc. - EIR, 2000-09-15
September, 2000 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2000-09-15
January, 2000 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2000-08-22
May, 2000 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2000-05-04
December, 2002 EIR Woodstock Sterile Solutions - EIR, 2002-12-18
June, 2006 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2006-06-29
September, 2001 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2001-08-28
May, 2005 FDA 483 Eli Lilly and Company - Form 483, 2005-05-19
March, 2005 FDA 483 ACS DOBFAR SPA - Form 483, 2005-03-24
May, 2008 FDA 483 Hydrox Laboratories - Form 483, 2008-05-09
January, 2000 EIR Fresenius Kabi USA, LLC - EIR, 2000-01-11
April, 2008 FDA 483 Ferring GmbH - Form 483, 2008-04-25
September, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-08-17
January, 2008 FDA 483 Bodycote Testing Group - Polymers - Form 483, 2008-01-29
September, 2003 EIR Bespak HC Limited - EIR, 2003-12-17
July, 2002 EIR Nanophase Technologies Corporation - EIR, 2002-07-29
May, 2005 FDA 483 Response Eli Lilly and Company - Form 483R, 2005-05-19
March, 2002 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2002-09-03
September, 2005 EIR Rising Pharma Holdings, Inc. - EIR, 2005-09-08
May, 2000 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2000-05-04
September, 2003 FDA 483 Aventis Pharma, Ltd. - Form 483, 2003-09-05
November, 2001 FDA 483 Aventis Pharma Specialties - Form 483, 2001-11-27
June, 2002 FDA 483 Labcorp Drug Development Inc. - Form 483, 2002-06-04
September, 2003 FDA 483 Response SF-Chem - Form 483R, 2003-10-23
November, 2001 EIR Sanofi Winthrop Industrie - EIR, 2001-11-27
August, 2003 FDA 483 Degussa Limited - Form 483, 2003-08-29
August, 2002 EIR Laborchemie Apolda GmbH - EIR, 2002-08-28
September, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-09-07
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
May, 2000 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2000-05-22
November, 2000 EIR Pfizer Ireland Pharmaceuticals - EIR, 2000-11-03
February, 2008 EIR ANDERSONBRECON INC. - EIR, 2008-02-05
June, 2002 FDA 483 Labcorp Drug Development Inc. - Form 483, 2002-03-22
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
June, 2002 EIR Labcorp Drug Development Inc. - EIR, 2002-05-30
March, 2008 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2008-03-18
November, 2002 FDA 483 Hydrox Laboratories - Form 483, 2002-11-26
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
September, 2001 FDA 483 Baxter Healthcare Corporation - Form 483, 2001-08-17
July, 2002 EIR Nanophase Technologies Corporation - EIR, 2002-07-25
April, 2001 FDA 483 Response AbbVie Inc. - Form 483R, 2001-05-18
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
May, 2004 FDA 483 Bigmar-Bioren Pharmaceuticals SA - Form 483, 2004-05-13
May, 2002 FDA 483 Response Eli Lilly and Company - Form 483R, 2002-05-30
June, 2002 FDA 483 Response Labcorp Drug Development Inc. - Form 483R, 2002-06-14
May, 2002 FDA 483 Eli Lilly & Company - Form 483, 2002-05-30
March, 2005 EIR ACS DOBFAR SPA - EIR, 2005-03-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more